Probiotic yeast found to have positive effects on the human microbiome
A study financed by the U.S pharmaceutical company Biocodex, investigated the effects of Saccharomyces boulardii (a probiotic yeast), and a commonly prescribed antibiotic Amoxicillin/Clavulanate, on the microbiome of the healthy human digestive tract.
However, when patients were given Saccharomyces boulardii alongside a course of antibiotics, the study showed that the populations of good and bad bacteria in the GI tract were kept in a healthy balance.
The Executive Vice President of Biocodex, Marc Rohman, stated that: ‘These findings demonstrate that this probiotic yeast, now proven to preserve gut flora balance, even when an antibiotic is on board, can significantly contribute to preventative health care’.
For further reading about antibiotics, you may be interested in: